TY - JOUR
T1 - ADHD medication dispensing trends in Dutch youth before and after the implementation of the Youth Act (2010–2022)
AU - Ringeling, Lisa T.
AU - Srivastava, Aarushi
AU - Gangapersad, Ravish N.
AU - Bos, Jens H.J.
AU - de Winter, Brenda C.M.
AU - Hak, Eelko
AU - Hillegers, Manon H.J.
AU - Koch, Birgit C.P.
AU - Schuiling-Veninga, Catharina C.M.
AU - Dierckx, Bram
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/6/23
Y1 - 2025/6/23
N2 - OBJECTIVE: The Youth Act, implemented by the Dutch government in 2015, aimed to provide more efficient, coherent, and cost-effective care tailored to the specific needs of children, while also reducing medicalization. Between 2003 and 2013, there was a four-fold increase in methylphenidate prescriptions among Dutch children aged 4 to 18 years. However, the impact of the Youth Act on the ADHD medication dispensing remains unassessed. This study investigated changes in ADHD medication dispensing patterns among Dutch youth following the implementation of the Youth Act.METHOD: A before-after retrospective cohort study was conducted using data from the Dutch community pharmacy-based IADB.nl database among 137,684 youths aged 0-19 years using ADHD medication between 2010 and 2022.RESULTS: A significant decrease in overall ADHD medication dispensing prevalence rates per thousand youths was observed in 2022 compared to 2015 (35.2 vs. 45.7, p < 0.001). Methylphenidate accounted for approximately 87% of all ADHD medication dispensing. Incidence rates decreased significantly among children aged 7-12 from 2015 to 2022 (9 vs. 7.3, p < 0.001), while incidence rates increased significantly in adolescent youths (4 vs. 4.8, p = 0.008), particularly among adolescent females (3.5 vs. 5.3, p < 0.001). Females had lower prevalence rates and shorter durations of ADHD medication use compared to males, with no difference in daily dose observed.CONCLUSION: ADHD medication dispensing among Dutch youth declined following the 2015 implementation of the Youth Act. However, other factors such as the DSM-5 revision, COVID-19, and medication shortages likely contributed to this decrease, suggesting a multifactorial explanation for the observed changes in ADHD medication dispensing.
AB - OBJECTIVE: The Youth Act, implemented by the Dutch government in 2015, aimed to provide more efficient, coherent, and cost-effective care tailored to the specific needs of children, while also reducing medicalization. Between 2003 and 2013, there was a four-fold increase in methylphenidate prescriptions among Dutch children aged 4 to 18 years. However, the impact of the Youth Act on the ADHD medication dispensing remains unassessed. This study investigated changes in ADHD medication dispensing patterns among Dutch youth following the implementation of the Youth Act.METHOD: A before-after retrospective cohort study was conducted using data from the Dutch community pharmacy-based IADB.nl database among 137,684 youths aged 0-19 years using ADHD medication between 2010 and 2022.RESULTS: A significant decrease in overall ADHD medication dispensing prevalence rates per thousand youths was observed in 2022 compared to 2015 (35.2 vs. 45.7, p < 0.001). Methylphenidate accounted for approximately 87% of all ADHD medication dispensing. Incidence rates decreased significantly among children aged 7-12 from 2015 to 2022 (9 vs. 7.3, p < 0.001), while incidence rates increased significantly in adolescent youths (4 vs. 4.8, p = 0.008), particularly among adolescent females (3.5 vs. 5.3, p < 0.001). Females had lower prevalence rates and shorter durations of ADHD medication use compared to males, with no difference in daily dose observed.CONCLUSION: ADHD medication dispensing among Dutch youth declined following the 2015 implementation of the Youth Act. However, other factors such as the DSM-5 revision, COVID-19, and medication shortages likely contributed to this decrease, suggesting a multifactorial explanation for the observed changes in ADHD medication dispensing.
KW - ADHD medication
KW - Dosages
KW - Duration of use
KW - Dutch youth
KW - Incidence
KW - Prevalence
KW - Psychostimulants
KW - Youth Act
UR - https://www.scopus.com/pages/publications/105008819931
U2 - 10.1007/s00787-025-02791-w
DO - 10.1007/s00787-025-02791-w
M3 - Article
C2 - 40549174
AN - SCOPUS:105008819931
SN - 1018-8827
JO - European Child and Adolescent Psychiatry
JF - European Child and Adolescent Psychiatry
ER -